Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF [Phase 2]
Tenax Therapeutics conducted a Phase 2 trial to evaluate the hemodynamic effects of levosimendan in patients with pulmonary hypertension ass…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
A University Medical Center Goettingen trial is evaluating whether arterial stiffening can predict diastolic dysfunction and heart failure w…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension
Clinical trial update reporting validation of a machine learning model to distinguish post-capillary pulmonary hypertension, currently recru…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF [NA]
Clinical trial evaluating the effects of a high-fiber diet combined with high-intensity interval training in patients with heart failure wit…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Use of SGLT2i in noHCM With HFpEF [Phase 4]
A Phase 4 clinical trial is recruiting to evaluate the use of SGLT2 inhibitors in non-obstructive hypertrophic cardiomyopathy with heart fai…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
A clinical trial investigating cardio-fistular recirculation in patients with heart failure with preserved ejection fraction has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF [Phase 4]
Phase 4 pilot study evaluating deprescribing beta-blockers using N-of-1 trials in patients with heart failure with preserved ejection fracti…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction [Phase 4]
Phase 4 trial update evaluating the efficacy of enavogliflozin in heart failure with preserved ejection fraction (HFpEF).
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction [Phase 2, Phase 3]
Phase 2/3 clinical trial update investigating reversal of microvascular dysfunction in heart failure with preserved ejection fraction.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF) [Phase 2]
Phase 2 trial evaluating potassium nitrate (KNO3) versus potassium chloride (KCl) on oxygen uptake in heart failure with preserved ejection …
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Cilostazol for HFpEF [Phase 2]
Phase 2 trial update for cilostazol in heart failure with preserved ejection fraction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure [Phase 4]
Phase 4 clinical trial evaluating metabolic mechanisms of ertugliflozin in patients with diastolic heart failure and type 2 diabetes was ter…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Carvedilol in HF With Preserved EF [Phase 4]
A Phase 4 clinical trial update evaluating carvedilol in heart failure with preserved ejection fraction (HFpEF).
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the addition of metformin to SGLT2 inhibitors in patients with type 2 diabetes and heart failure with …
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Dapagliflozin (DAPA) Effects in HFpEF [Phase 2]
Phase 2 trial investigating dapagliflozin effects in heart failure with preserved ejection fraction has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction [Phase 2]
Phase 2 trial investigating the addition of metformin in obese, non-diabetic patients with heart failure with preserved ejection fraction (d…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life [Phase 4]
Phase 4 trial evaluating ferric derisomaltose for improving exercise capacity and quality of life in patients with acute heart failure and i…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction [Phase 4]
Phase 4 clinical trial updates empagliflozin for heart failure with preserved ejection fraction and microvascular dysfunction.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure. [Phase 3]
Phase 3 trial evaluating dapagliflozin for heart failure with preserved ejection fraction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Impact of Beta-blockers on Physical Function in HFpEF [Phase 4]
Phase 4 trial update evaluating the impact of beta-blockers on physical function in heart failure with preserved ejection fraction (HFpEF); …
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Study of Verinurad in Heart Failure With Preserved Ejection Fraction [Phase 2]
Phase 2 trial of verinurad in heart failure with preserved ejection fraction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Cell Therapy in HFpEF [Phase 2]
Phase 2 clinical trial update of a cell therapy for heart failure with preserved ejection fraction has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training) [Phase 2]
Phase 2 trial updating the use of inorganic nitrite to enhance exercise training in heart failure with preserved ejection fraction (HFpEF).
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure [NA]
A completed clinical trial evaluating pacemakers for treating slow heart rate in heart failure patients, including those with preserved ejec…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing gemigliptin to glimepiride on cardiac diastolic function in type 2 diabetes patients.